Effects of Travoprost on Neovascular Glaucoma

Federal University of São Paulo40 enrolled

Overview

Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Neovascular Glaucoma

Interventions

TravoprostDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Neovascular glaucoma of known cause * Older than 18 years * Previously submitted to retinal photocoagulation * Under medical treatment to glaucoma Exclusion Criteria: * Need of antiglaucomatous surgery * Previous ocular surgery in the last 6 months * Pregnancy

Locations (1)

Federal University of São Paulo

São Paulo, São Paulo, Brazil

Outcomes

Primary Outcomes

Intraocular pressure

Secondary Outcomes

Inflammation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.